A chimeric measles virus with canine distemper envelope protects ferrets from lethal distemper challenge

Vaccine

Volumn 27, Issue 36, 2009, Pages 4961-4966

  Rouxel, Ronan Nicolas ^a   Svitek, Nicholas ^a   von Messling, Veronika ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Ferret model; Morbillivirus; Recombinant vaccine

Indexed keywords

5804PEH VACCINE; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G ANTIBODY; MVVAC58PENV VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY TEMPERATURE; CANINE DISTEMPER MORBILLIVIRUS; CARNIVORE; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; DOG DISEASE; DRUG EFFICACY; DRUG SAFETY; FERRET; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKOPENIA; MALE; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RASH; VACCINATION; VIRUS ENVELOPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BODY TEMPERATURE; BODY WEIGHT; DISTEMPER; DISTEMPER VIRUS, CANINE; FERRETS; GENETIC VECTORS; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; LEUKOCYTES; MALE; MEASLES VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 67650588773     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.096     Document Type: Article

References (30)

1. Moss W.J., and Griffin D.E. Global measles elimination. Nat Rev Microbiol 4 12 (2006) 900-908
2. von Messling V., Springfeld C., Devaux P., and Cattaneo R. A ferret model of canine distemper virus virulence and immunosuppression. J Virol 77 23 (2003) 12579-12591
3. Barrett T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet Microbiol 69 1/2 (1999) 3-13
4. van de Bildt M.W., Kuiken T., Visee A.M., Lema S., Fitzjohn T.R., and Osterhaus A.D. Distemper outbreak and its effect on African wild dog conservation. Emerg Infect Dis 8 2 (2002) 211-213
5. Kuiken T., Kennedy S., Barrett T., Van de Bildt M.W., Borgsteede F.H., Brew S.D., et al. The 2000 canine distemper epidemic in Caspian seals (Phoca caspica): pathology and analysis of contributory factors. Vet Pathol 43 3 (2006) 321-338
6. Roelke-Parker M.E., Munson L., Packer C., Kock R., Cleaveland S., Carpenter M., et al. A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 379 6564 (1996) 441-445
7. Stephensen C.B., Welter J., Thaker S.R., Taylor J., Tartaglia J., and Paoletti E. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection. J Virol 71 2 (1997) 1506-1513
8. Beauverger P., Buckland R., and Wild T.F. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J Gen Virol 74 Pt 11 (1993) 2357-2363
9. Sheshberadaran H., Norrby E., McCullough K.C., Carpenter W.C., and Orvell C. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol 67 Pt 7 (1986) 1381-1392
10. Appel M.J., Shek W.R., Shesberadaran H., and Norrby E. Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper. Arch Virol 82 1/2 (1984) 73-82
11. Devaux P., von Messling V., Songsungthong W., Springfeld C., and Cattaneo R. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360 1 (2007) 72-83
12. von Messling V., Milosevic D., and Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci USA 101 39 (2004) 14216-14221
13. Suter S.E., Chein M.B., von Messling V., Yip B., Cattaneo R., Vernau W., et al. In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma. Clin Cancer Res 11 (2005) 1579-1587
14. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., and Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77 1 (1989) 51-59
15. Anderson D.E., and von Messling V. Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J Virol 82 21 (2008) 10510-10518
16. Martin A., Staeheli P., and Schneider U. RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication. J Virol 80 12 (2006) 5708-5715
17. von Messling V., Harder T.C., Moennig V., Rautenberg P., Nolte I., and Haas L. Rapid and sensitive detection of immunoglobulin M (IgM) and IgG antibodies against canine distemper virus by a new recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay. J Clin Microbiol 37 4 (1999) 1049-1056
18. de Swart R.L., Ludlow M., de Witte L., Yanagi Y., van Amerongen G., McQuaid S., et al. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3 11 (2007) e178
19. Appel M.J., and Summers B.A. Pathogenicity of morbilliviruses for terrestrial carnivores. Vet Microbiol 44 2-4 (1995) 187-191
20. Carpenter J.W., Appel M.J., Erickson R.C., and Novilla M.N. Fatal vaccine-induced canine distemper virus infection in black-footed ferrets. J Am Vet Med Assoc 169 9 (1976) 961-964
21. Mahapatra M., Parida S., Baron M.D., and Barrett T. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex. J Gen Virol 87 Pt 7 (2006) 2021-2029
22. von Messling V., Zimmer G., Herrler G., Haas L., and Cattaneo R. The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol 75 14 (2001) 6418-6427
23. Brown D.D., Collins F.M., Duprex W.P., Baron M.D., Barrett T., and Rima B.K. 'Rescue' of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins. J Gen Virol 86 Pt 4 (2005) 1077-1081
24. Parida S., Mahapatra M., Kumar S., Das S.C., Baron M.D., Anderson J., et al. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol 88 Pt 7 (2007) 2019-2027
25. Tatsuo H., Ono N., and Yanagi Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 75 13 (2001) 5842-5850
26. Parks C.L., Lerch R.A., Walpita P., Wang H.P., Sidhu M.S., and Udem S.A. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 75 2 (2001) 910-920
27. Valsamakis A., Kaneshima H., and Griffin D.E. Strains of measles vaccine differ in their ability to replicate in an damage human thymus. J Infect Dis 183 3 (2001) 498-502
28. Condack C., Grivel J.C., Devaux P., Margolis L., and Cattaneo R. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196 4 (2007) 541-549
29. Devaux P., Hodge G., McChesney M.B., and Cattaneo R. Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol 82 11 (2008) 5359-5367
30. Welter J., Taylor J., Tartaglia J., Paoletti E., and Stephensen C.B. Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection. Vaccine 17 4 (1999) 308-318